Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma

Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma J Cancer Res Clin Oncol (2017) 143:1811–1814 DOI 10.1007/s00432-017-2426-2 ORIGINAL ARTICLE – CLINICAL ONCOLOGY Conversion of hormone and HER‑2 receptor in metachronous neck metastases from breast carcinoma 1 2 3 4 Andreas Nauroth · Matthias Kalder · Marion Rössler · Gunnar Wichmann · 4 4 Andreas Dietz · Susanne Wiegand Received: 4 April 2017 / Accepted: 13 April 2017 / Published online: 20 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract of these markers in the primary tumor. As such changes Purpose Metastases are a common event in breast cancer. can occur during disease progression, the evaluation of The expression of estrogen receptor (ER), progesterone biomarkers in metastatic sites should be mandatory, when- receptor (PR) and human epidermal growth factor recep- ever possible, to ensure that patients are receiving the most tor 2 (HER-2) is essential for therapy and prognosis, and effective treatment at all times. their conversion during disease progression potentially affects the treatment regimen. The aim was to analyze the Keywords Breast cancer · Lymph node metastases · estrogen, progesterone and HER-2 receptor expression in Estrogen · Progesterone · HER-2 · Neck metastases primary tumors and metachronous neck metastases from patients with breast cancer. Methods A retrospective http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Conversion of hormone and HER-2 receptor in metachronous neck metastases from breast carcinoma

Loading next page...
 
/lp/springer_journal/conversion-of-hormone-and-her-2-receptor-in-metachronous-neck-uWq4LBzznt
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2426-2
Publisher site
See Article on Publisher Site

Abstract

J Cancer Res Clin Oncol (2017) 143:1811–1814 DOI 10.1007/s00432-017-2426-2 ORIGINAL ARTICLE – CLINICAL ONCOLOGY Conversion of hormone and HER‑2 receptor in metachronous neck metastases from breast carcinoma 1 2 3 4 Andreas Nauroth · Matthias Kalder · Marion Rössler · Gunnar Wichmann · 4 4 Andreas Dietz · Susanne Wiegand Received: 4 April 2017 / Accepted: 13 April 2017 / Published online: 20 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract of these markers in the primary tumor. As such changes Purpose Metastases are a common event in breast cancer. can occur during disease progression, the evaluation of The expression of estrogen receptor (ER), progesterone biomarkers in metastatic sites should be mandatory, when- receptor (PR) and human epidermal growth factor recep- ever possible, to ensure that patients are receiving the most tor 2 (HER-2) is essential for therapy and prognosis, and effective treatment at all times. their conversion during disease progression potentially affects the treatment regimen. The aim was to analyze the Keywords Breast cancer · Lymph node metastases · estrogen, progesterone and HER-2 receptor expression in Estrogen · Progesterone · HER-2 · Neck metastases primary tumors and metachronous neck metastases from patients with breast cancer. Methods A retrospective

Journal

Journal of Cancer Research and Clinical OncologySpringer Journals

Published: Apr 20, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off